Fred Alger Management, LLC Biogen Inc. Transaction History

Fred Alger Management, LLC

$20.1 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $2.95 Million - $3.55 Million	13,235 New	13,235 $3.42 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $39.5 Million - $45.6 Million	-143,458 Reduced 53.24%	125,980 $35.9 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $16.1 Million - $18.3 Million	-62,627 Reduced 18.86%	269,438 $74.9 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $47.5 Million - $57.7 Million	188,033 Added 130.55%	332,065 $92 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $28 Million - $38.7 Million	144,032 New	144,032 $38.5 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $24.2 Million - $31.6 Million	-85,613 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $17.6 Million - $28.2 Million	67,888 Added 383.01%	85,613 $29.6 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $3.34 Million - $3.92 Million	13,766 Added 347.71%	17,725 $4.96 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $931,336 - $1.4 Million	3,942 Added 23188.24%	3,959 $969,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $1.02 Million - $1.18 Million	-3,850 Reduced 99.56%	17 $5,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $41.2 Million - $54.5 Million	-159,223 Reduced 97.63%	3,867 $1.04 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $6.52 Million - $8.27 Million	24,245 Added 17.46%	163,090 $51.6 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $30.6 Million - $42.2 Million	138,845 New	138,845 $41.2 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $9,132 - $10,242	-42 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $433,974 - $478,363	-1,979 Reduced 97.92%	42 $10,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $46.6 Million - $72.9 Million	-215,110 Reduced 99.07%	2,021 $478,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $22.4 Million - $28.4 Million	-80,405 Reduced 27.02%	217,131 $65.3 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $83.6 Million - $109 Million	284,735 Added 2224.32%	297,536 $105 Million
Q2 2018 Jul 19, 2018	SELL	$257.52 - $306.91 $417,182 - $497,194	-1,620 Reduced 11.23%	12,801 $3.72 Million
Q1 2018 May 10, 2018	BUY	$260.13 - $367.91 $284,061 - $401,757	1,092 Added 8.19%	14,421 $3.95 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $1.7 Million - $1.91 Million	5,537 Added 71.06%	13,329 $4.25 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $2.19 Million - $2.57 Million	7,792	7,792 $2.44 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account